Researchers prevent cancer spread by blocking tissue scarring

What to fear most if faced by a cancer diagnosis is the spread of the cancer to other parts of the body. This process called metastasis accounts for over 90% of cancer patient deaths and therefore is a strong focus for cancer researchers. Researchers at BRIC, University of Copenhagen have shown that the enzyme Lysyl Oxidase (LOX) can create a "scarred" microenvironment that enhances cancer spreading. By blocking activity of the LOX enzyme, the researchers succeeded in significantly decreasing metastasis in a model of breast cancer.

'When we inhibit the activity of LOX in our cancer models, we show a dramatic reduction in metastasis. This suggests that therapeutic targeting of LOX can keep the tumour microenvironment "healthy" and thereby decrease metastasis, says Associate Professor Janine Erler from BRIC, who has headed the research.

Metastasis of breast cancer cells in the lung

In humans, LOX is an enzyme that is produced in response to tissue injury or chronic inflammation in our organs. It reacts to damage signals and "glues" collagen molecules together to form the scar-like structure. The result can be a fibrotic environment. The new findings from Janine Erler's research group show that persistent injury to lung and liver results in a fibrotic microenvironment that supports the growth of new tumours, and thereby enhances metastasis of to these organs. Blocking LOX prevents the formation of this fibrotic , thereby preventing enhanced metastasis to these organs.

'It is well-known that signals from fibrotic tissues can enhance tumour progression and metastasis, but the underlying mechanisms have remained unclear - Our new results provide insight into the link between fibrosis and . Such a biological understanding is crucial if we are to develop effective therapies preventing tumour metastasis, says PostDoc Thomas Cox from Janine Erler's laboratory, who undertook the experimental investigation.

Development of new anti-fibrotic therapies

Currently, LOX-targeting therapies are under development for use in the clinic against cancer, as it has been known for some while that metastatic tumours express increased amounts of LOX. Yet, the new results from Janine Erler's group are the first to show that LOX promotes distant metastasis through structural changes in the organ microenvironments in response to persistent injury. The next step for the researchers is to dig deeper into the mechanisms underlying the relationship between fibrosis and cancer metastasis, and also to test their findings in other cancer models such as gastric and colon cancer.

'Further, our study indicates that LOX-targeting therapy can be relevant not only for cancer patients, but also to prevent fibrosis in patients with or patients who has been exposed to persistent organ injury. This opens up for an even wider applicability of our biological findings, which strongly motivates the basic research in my laboratory, says Janine Erler.

add to favorites email to friend print save as pdf

Related Stories

Tissue tension regulates tumor progression

Nov 23, 2009

(PhysOrg.com) -- UCSF scientists have shown for the first time that the rigidity of a tissue can induce cancer. The research team identified an enzyme that is crucial for regulating tissue stiffness and demonstrated that ...

Preventing Prostate Cancer to Bone Metastasis

Jul 13, 2009

(PhysOrg.com) -- In new research on prostate cancer to bone metastasis, Dr. Phillip Trackman of Boston University Henry M. Goldman School of Dental Medicine explains that the lysyl oxidase pro-peptide (LOX-PP) inhibits prostate ...

Discovery reveals important clues to cancer metastasis

Oct 11, 2012

In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority ...

Recommended for you

The fine line between breast cancer and normal tissues

9 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

10 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

13 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

14 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments